What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Organic chemistry
- Pharmacology
His scientific interests lie mostly in Pharmacology, Receptor, Internal medicine, Endocrinology and Opioid.
He interconnects Agonist, Opioid receptor, Antagonist, Dopamine and TLR4 in the investigation of issues within Pharmacology.
His work in Antagonist tackles topics such as Self-administration which are related to areas like Ethanol.
His biological study spans a wide range of topics, including In vitro and Stereochemistry.
His Stereochemistry research focuses on Binding site and how it relates to Membrane and Receptor complex.
His Opioid research includes elements of Morphine and Nociception.
His most cited work include:
- Cannabinoid receptor localization in brain (1831 citations)
- Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study (1797 citations)
- Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. (761 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Pharmacology, Stereochemistry, Receptor, Internal medicine and Endocrinology.
His research in Pharmacology intersects with topics in Agonist, Antagonist, Opioid and Dopamine.
His studies in Dopamine integrate themes in fields like Reuptake and Serotonin.
He combines subjects such as Ligand, Opioid receptor, Chemical synthesis and Binding site with his study of Stereochemistry.
His Binding site research is multidisciplinary, incorporating elements of Phencyclidine, Membrane and Enkephalin.
Internal medicine is a component of his Antalarmin, Receptor antagonist, Opioid peptide and Corticotropin-releasing hormone studies.
He most often published in these fields:
- Pharmacology (40.00%)
- Stereochemistry (27.93%)
- Receptor (26.30%)
What were the highlights of his more recent work (between 2012-2021)?
- Pharmacology (40.00%)
- Receptor (26.30%)
- Internal medicine (20.87%)
In recent papers he was focusing on the following fields of study:
Kenner C. Rice mainly investigates Pharmacology, Receptor, Internal medicine, Endocrinology and Antagonist.
His work deals with themes such as Agonist, Dopamine and Opioid, which intersect with Pharmacology.
Kenner C. Rice usually deals with Agonist and limits it to topics linked to Serotonin and Receptor antagonist.
His work in Receptor addresses issues such as Stereochemistry, which are connected to fields such as Structure–activity relationship.
His research ties Eating disorders and Internal medicine together.
The Antagonist study combines topics in areas such as Ethanol, Tachykinin receptor 1 and Addiction.
Between 2012 and 2021, his most popular works were:
- Morphine paradoxically prolongs neuropathic pain in rats by amplifying spinal NLRP3 inflammasome activation. (163 citations)
- In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity. (114 citations)
- DAT isn't all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling. (107 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Organic chemistry
- Dopamine
Kenner C. Rice spends much of his time researching Pharmacology, Endocrinology, Internal medicine, Antagonist and Bath salts.
His Pharmacology study integrates concerns from other disciplines, such as Nucleus accumbens, Dopamine, Opioid and TLR4.
His Endocrinology research incorporates elements of Receptor, Complex regional pain syndrome and Rimonabant.
A large part of his Receptor studies is devoted to Agonist.
His Internal medicine research includes themes of Eating disorders and Sensitization.
His Antagonist research is multidisciplinary, relying on both Ethanol, Heroin, 5-HT2C receptor, Addiction and Heart rate.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
